GlassScriptPhysician profile
Charles W Davis
NPI 1083758536
$4,700.15
in general payments reported to CMS, 2019-2025
13 companies · $65.90 in 2025
The $65.90 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.23 · 2021: $1,825 · 2022: $1,981 · 2023: $588 · 2024: $199 · 2025: $65.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $531 · Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $530.99 |
| Food and Beverage | $321.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. | $1,824.71 | 2021 | |
| Corelink, LLC | $1,213.40 | 2022-2023 | |
| Mvp Orthopedics INC | $1,200.00 | 2022 | |
| Cerapedics INC. | $131.70 | 2022 | |
| Coastal Medical Technologies LLC | $60.40 | 2024 | |
| Innovasis INC | $55.40 | 2024 | |
| Si-Bone, INC. | $48.94 | 2024 | |
| Vb Spine LLC | $39.21 | 2025 | Avs Anchor-C, Everest Spinal System |
| Centinel Spine, LLC | $34.35 | 2024 | Prodisc C Vivo |
| Orthofix Medical, INC. | $30.01 | 2019-2023 | 7d Surgical System |
| Pfizer INC. | $26.69 | 2025 | |
| Medtronic USA, INC. | $18.63 | 2019 | |
| Spineology INC. | $16.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.